Form D · Pharmaceuticals
Vogenx, Inc.
Raleigh, NC · CIK 0001903784
Offering snapshot reported Jan 7, 2026 · SEC filing
- Reported sold
- $750K Offering amount: $5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2026 | Initial | $750,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-569148
Source: Form D, filed Jan 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tim Boris | Director |
| Steven Delmar | Director, Executive |
| Richard Gorman | Director |
| James Green | Director, Executive |
| Pete Pieraccini | Director |
| William Wilkison | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3901 Barrett Drive Suite 300, P.O. Box 19469
Raleigh, NC, 27609
Phone: 9196595677
Raleigh, NC, 27609
Phone: 9196595677